AUG 14, 2026 · PHASE 2 TRIAL
A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)
ClinicalTrials.gov
This is a recruiting Phase 2 single-arm trial with no posted results; it represents early-stage investigation of a three-drug combination for brain metastases from NSCLC.
Reported
Planned enrollment46
Study phasePhase 2
Primary outcome measureConfirmed Intracranial Objective Response R…